Resources

Viral Sensitizers Unleash Host Cell Potential to Enhance AAV Production
April 20th, 2025PosterCell & Gene Therapies
Evaluation of Small Molecule Antagonists of Cellular Innate Immunity for T-cell Manufacturing
April 20th, 2025PosterCell & Gene Therapies
Harnessing the Power of High-Throughput Virology and DoE for Rapid Vector Optimization
April 20th, 2025PosterCell & Gene Therapies
Increased Viral Vector Yield: Development and Scale-Up Validation of Small Molecule Enhancers
April 20th, 2025PosterCell & Gene Therapies, Vaccines
The Impacts of Suppressing Cellular Innate Immune Responses on AAV Yields During Production
April 20th, 2025PosterCell & Gene Therapies
Increase Viral Vector Yield: Small Molecule Enhancers Validation at Multiple Scales
April 20th, 2025PosterCell & Gene Therapies
A Novel Approach to Enhancing Viral Vector Manufacturing Using Small Molecules
April 20th, 2025PosterCell & Gene Therapies
Bioprocess Modelling of Upstream Viral Vector Production
April 20th, 2025PosterCell & Gene Therapies
Development and Scale Up Validation of Small Molecule Viral Sensitizers for Increased Vaccine Manufacturing Yields
April 20th, 2025PosterVaccines
Increasing Vaccine Production Yields Using Small Molecules
April 20th, 2025PosterVaccines